HLA-B antibody (FITC)

Catalog No. ABIN201048

This anti-HLA-B antibody is a Mouse Monoclonal antibody detecting HLA-B in FACS. Suitable for Human and Monkey.

Quick Overview for HLA-B antibody (FITC) (ABIN201048)

Target: HLA-B (Major Histocompatibility Complex, Class I, B (HLA-B))

Reactivity: Human, Monkey

Host: Mouse

Clonality: Monoclonal

Conjugate: This HLA-B antibody is conjugated to FITC

Application: Flow Cytometry (FACS)

Product Details anti-HLA-B Antibody (FITC)

Specificity: Recognizes the human HLA-B7 antigen. Does not cross-react with HLA-B27 or other related antigens. It can be used to distinguish true HLA-B27 positives from false HLA-B27 positives (i. e. HLA-B7 positive) in the investigation of diseases such as ankylosing spondylitis and anterior uveitis. Species cross-reactivity: Cynomolgus monkey.

Purification: Protein G purified

Immunogen: Papain solubilized HLA-B7 antigen.

Type of Immunogen: Purified protein

Isotype: IgG1

Application Details

Application Notes: Approved: Flo

Usage: Suitable for use in Flow Cytometry. Flow Cytometry: Neat-1:10. Use 10 μL to label 1x1 x10⁶ or 100 μL whole blood. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: PBS,  pH 7.2, 1 % BSA, 0.1 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C,-20 °C

Storage Comment: Short term: 4°C
Long term: Add glycerol (40-50%) -20°C.

Target Details for HLA-B

Target: HLA-B (Major Histocompatibility Complex, Class I, B (HLA-B))

Alternative Name: HLA-B

Background: Name/Gene ID: HLA-B

Synonyms: HLA-B, HLAB, MHC Class I HLA heavy chain, Leukocyte antigen class I-B, SPDA1

Gene ID: 3106

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response